![Craig Tooman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Craig Tooman
Directeur/Membre du Conseil chez
ROQT THER
Fortune : 60 275 $ au 30/11/2025
Profil
Craig Allen Tooman was the founder of Stockbourne LLC, founded in 2011, where the title held was Principal from 2011 to 2012.
Current jobs include Director at Silence Therapeutics, Inc. since 2021; Director at Verte Therapeutics LLC; Independent Non-Executive Director at Coiled Therapeutics Plc starting in 2026; Member-Supervisory Board at CureVac SE since 2019; and Independent Member-Supervisory Board at CureVac NV since 2019.
Former jobs include President, Chief Executive Officer & Director at Aratana Therapeutics, Inc. in 2019; Chief Executive Officer at Avanzar Medical, Inc. from 2012 to 2014; President, CEO & Executive Director at Silence Therapeutics Plc from 2022 to 2025; Independent Director at InSite Vision, Inc. from 2011 to 2015; Director at Xanodyne Pharmaceuticals, Inc.; Director at Aratana Therapeutics NV; Chief Operating & Financial Officer, Director at Vyome Therapeutics, Inc. from 2019 to 2021; Director at Vet Therapeutics, Inc.; Director at ViroVet NV; Independent Non-Executive Director at Ondine Biomedical, Inc. from 2021 to 2024; Chief Financial Officer, Executive VP & Head-IR at Enzon Pharmaceuticals, Inc. in 2010; Vice President-Investor Relations at Pharmacia & Upjohn, Inc.; SVP-Strategic Planning & Corporate Communications at ILEX Oncology, Inc. in 2005; Chief Financial Officer & Senior Vice President at Ikaria, Inc. from 2010 to 2011; Vice President-Investor Relations at Pharmacia Corp.
Education includes an MBA from The University of Chicago and undergraduate studies at Kalamazoo College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SILENCE THERAPEUTICS PLC 0,02 % | 31/03/2026 | 33 486 ( 0,02 % ) | 60 275 $ | 30/11/2025 |
Postes actifs de Craig Tooman
| Sociétés | Poste | Début |
|---|---|---|
| ROQT THER | Directeur/Membre du Conseil | 01/03/2026 |
CureVac SE
 CureVac SE BiotechnologyHealth Technology Develops tumor immunotherapies | Directeur/Membre du Conseil | 24/06/2019 |
Stockbourne LLC | Fondateur | 01/01/2011 |
Anciens postes connus de Craig Tooman
| Sociétés | Poste | Fin |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Directeur Général | 14/12/2025 |
| CUREVAC | Directeur/Membre du Conseil | 01/01/2025 |
| ONDINE BIOMEDICAL INC. | Directeur/Membre du Conseil | 16/09/2024 |
Vyome Therapeutics, Inc.
 Vyome Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage pharmaceutical company that develops medicines to treat immuno-inflammatory diseases | Directeur Financier/CFO | 01/01/2021 |
| INSITE VISION INC. | Directeur/Membre du Conseil | 02/11/2015 |
Formation de Craig Tooman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
50
Relations au 1er degré
23
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 23 |
|---|---|
Enzon Pharmaceuticals, Inc.
 Enzon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative therapeutics for cancer patients | Health Technology |
InSite Vision, Inc.
 InSite Vision, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceutical products | Health Technology |
Pharmacia & Upjohn, Inc.
 Pharmacia & Upjohn, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutical Preparations | Health Technology |
ILEX Oncology, Inc.
 ILEX Oncology, Inc. BiotechnologyHealth Technology Develops drugs to treat and prevent cancer | Health Technology |
Ondine Biomedical, Inc.
 Ondine Biomedical, Inc. BiotechnologyHealth Technology Engages in the development of non-antibiotic therapies for the treatment of a broad spectrum of bacterial, fungal and viral infections | Health Technology |
Ikaria, Inc.
 Ikaria, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics | Health Technology |
CureVac SE
CureVac SE BiotechnologyHealth Technology Develops tumor immunotherapies | Health Technology |
Aratana Therapeutics, Inc.
 Aratana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercialization therapeutics for dogs & cats | Health Technology |
Silence Therapeutics Plc
 Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kalamazoo College
 Kalamazoo College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xanodyne Pharmaceuticals, Inc.
 Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
Aratana Therapeutics NV
 Aratana Therapeutics NV Pharmaceuticals: OtherHealth Technology Develops and markets drugs to treat viral infections in both pet animals and livestock | Health Technology |
Vyome Therapeutics, Inc.
Vyome Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage pharmaceutical company that develops medicines to treat immuno-inflammatory diseases | Health Technology |
Avanzar Medical, Inc.
 Avanzar Medical, Inc. Medical/Nursing ServicesHealth Services Operates oncology clinic | Health Services |
Stockbourne LLC | |
Vet Therapeutics, Inc.
 Vet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibodies and pharmaceutical products for animals | Health Technology |
ViroVet NV
 ViroVet NV Pharmaceuticals: MajorHealth Technology Focuses on discovery, licensing and development of biopharmaceutical products for livestock | Health Technology |
CureVac NV
 CureVac NV BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops medicines based on messenger ribonucleic acid which includes prophylactic vaccines, oncology, and molecular therapies | Health Technology |
Silence Therapeutics, Inc. | |
Verte Therapeutics LLC
 Verte Therapeutics LLC BiotechnologyHealth Technology Develops drugs and delivery systems for animal therapeutics | Health Technology |
Roquefort Therapeutics Plc
 Roquefort Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops pre-clinical next generation medicines for cancer treatment | Health Technology |
